论文部分内容阅读
目的探讨小儿肺炎支原体肺炎(MPP)的临床疗效。方法我院诊治的60例小儿肺炎支原体肺炎患儿,随机将其分为观察组(采用阿奇霉素序贯疗法进行治疗)和对照组(采用红霉素序贯疗法进行治疗),每组各30例,对两组退热时间、咳嗽及肺部罗音消失时间,以及不良反应发生率进行观察和比较。结果与对照组相比,在退热时间、咳嗽及肺部罗音消失时间方面,观察组均明显缩短,P<0.05;30例观察组患者中,出现2例不良反应;30例对照组患者中,出现7例不良反应。与对照组相比(23.3%),观察组不良反应的发生率明显降低(6.7%),P<0.05,差异有统计学意义。结论对于小儿肺炎支原体肺炎,阿奇霉素序贯疗法显著提高临床疗效,并发症少。
Objective To investigate the clinical efficacy of mycoplasma pneumoniae pneumonia (MPP) in children. Methods Sixty children with mycoplasma pneumoniae pneumonia were randomly divided into observation group (treated with azithromycin sequential therapy) and control group (treated with sequential therapy with erythromycin), 30 cases in each group , The two groups of antipyretic time, cough and pulmonary rales disappear time, and the incidence of adverse reactions were observed and compared. Results Compared with the control group, in the time of fever, cough and disappearance of pulmonary rales, the observation group were significantly shorter, P <0.05; two cases of adverse reactions occurred in the 30 observation group; 30 patients in the control group Seven adverse reactions occurred. Compared with the control group (23.3%), the incidence of adverse reactions in the observation group was significantly lower (6.7%), P <0.05, the difference was statistically significant. Conclusion Mycoplasma pneumoniae pneumonia, sequential treatment of azithromycin significantly improve clinical efficacy, fewer complications.